Search

Your search keyword '"Parkhomenko, Alexander N"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Parkhomenko, Alexander N" Remove constraint Author: "Parkhomenko, Alexander N"
24 results on '"Parkhomenko, Alexander N"'

Search Results

1. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

2. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

3. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease

4. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

5. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

6. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

7. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

8. Third universal definition of myocardial infarction

9. †Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

10. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial

11. Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial

12. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

13. Association of matrix Gla protein gene allelic polymorphisms (G−7→A, T−138→C and Thr83→Ala) with acute coronary syndrome in the Ukrainian population

14. Documento de consenso de expertos. Tercera definición universal del infarto de miocardio

15. Universal definition of myocardial infarction

16. Third Universal Definition of Myocardial Infarction

17. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies(COMPASS) Trial

18. Third universal definition of myocardial infarction.

19. Perspectives: Rationale and design of the ISACS-TC (International Survey of Acute Coronary Syndromes in Transitional Countries) project

20. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.

21. Third universal definition of myocardial infarction.

22. Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population.

23. Universal definition of myocardial infarction.

24. Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.

Catalog

Books, media, physical & digital resources